Caris Life Sciences raises 12-month price target to $30.23
FactSet reference data via the Forecasts tab shows Caris Life Sciences’ 12-month price target was raised to $30.23, implying about 10% upside.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.